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Objectives: This study aimed to investigate the prevalence of antibiotic resis-
tance in fecal Escherichia coli isolates from healthy persons and patients with
diarrhea.
Methods: E. coli isolates (n Z 428) were obtained from fecal samples of
apparently healthy volunteers and hospitalized patients with diarrhea. Suscep-
tibility patterns of isolates to 16 antimicrobial agents were determined by agar
disc diffusion.
Results: Most E. coli isolates exhibited less than 10% resistance against imipe-
nem, cefotetan, aztreonam, cefepime, cefoxitin, amikacin and netilamicin,
although greater than 65% were resistant to ampicillin and tetracycline. No
significant difference in resistance rates for all tested antibiotics was found
between isolates from the healthy-and diarrheal-patient groups, including for
multi-drug resistance (pZ 0.22). The highest number of resistant antibiotics was
12 antibiotics. No significant differences in antibiotic resistance were found
among the sex and age strata for isolates from healthy individuals. However,
antibiotic resistance rates to cefoxitin, cefotaxime, amikacin, and netilamicin
were significantly higher in the isolates of men than those of women (p < 0.05) in
isolates from patients with diarrhea. Furthermore, isolates from patients with
diarrhea older than 40-years of age showed higher resistance to cefepime and
aztreonam (p < 0.05).
Conclusion: High resistance to the antibiotics most frequently prescribed for
diarrhea was found in isolates from patients with diarrhea and apparently
healthy individuals without any significant difference.ibuted under the terms of the Creative Commons Attribution Non-Commercial License
y-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in
is properly cited.
ol and Prevention. Published by Elsevier. All rights reserved.
Table 2. Antibiotic resistance patterns of E. coli strains
Antimicrobial agents
Antibiotic resistances (%) of isolates
People without
diarrhea
Patients
with diarrhea
ß-lactams
AM 77.3 76.5
ß-lactam/ß-lactamase inhibitor combinations
SAM 6.5 22.6
TZP 12.5 0.9
Cephems
CF 30 42.9
FEP 0.9 8.9
CTT 0 0
CTX 3.2 13.6
FOX 3.7 2.3
Carbapenems
IPM 0 0
Aminoglycosides
AN 9.6 2.1
GM 39.4 29.2
NN 31 17.9
NET 4.6 3.3
Tetracyclines
TE 66.5 66
42 S.-H. Cho, et al1. Introduction
Diarrheal diseases continue to be a health problem
worldwide. This is especially the case in developing
countries, where they are estimated to be responsible for
2.5 million infant deaths per year, with an annual
mortality rate of 4.9 per 1000 children and an incidence
of 3.2 episodes per child per year among children
younger than 5-years of age [1,2]. Antibiotic therapy in
hospitals is possibly the most important factor that
increases antibiotic-resistant microorganisms [3]. The
emergence, propagation, accumulation, and mainte-
nance of antimicrobial resistant pathogenic bacteria
have become significant health concerns, and lead to
increased morbidity, mortality, and health-care costs as
a result of treatment failures and longer hospital stays
[4e6].
A recent surveillance study in Korea demonstrated
the positive relationship between antibiotic use and
antibiotic resistance in several nosocomial pathogens
[7]. We therefore aimed to investigate the prevalence of
antibiotic resistance in fecal Escherichia coli isolates
obtained from hospitalized patients with diarrhea in
Korea compared with isolates from apparently-healthy
persons who had not visited a health clinic for at least
a year.Monobactams
ATM 1.4 9.4
Folate pathway inhibitors
SXT 58.3 44.8
AM Z ampicillin; AN Z amikacin; ATM Z aztreonam;
CF Z cephalothin; CTT Z cefotetan; CTX Z cefotaxime;
FEP Z cefepime; FOX Z cefoxitin; GM Z gentamicin;
IPM Z imipenem; NET Z netilamicin; NN Z tobramycin;
SAM Z ampicillin-sulbactam; SXT Z trimethoprim-sulfamethox-
azole; TE Z tetracycline; TZP Z piperacillin/tazobactam.2. Materials and Methods
2.1. Sampling of feces for surveillance study
The surveillance study was planned by the Labora-
tory of Enteric Infections of the Korean Center for
Disease Control and Prevention. Sampling was carried
out from 2004 to 2006 with the help of several public
health centers in Guri, Seongnam, and Yoeju in Korea.
Specimens were collected from 95 patients with diarrhea
who visited clinics because of diarrheal symptoms. The
control group comprised 110 apparently-healthy persons
living Guri, Seongnam, and Yoeju in Korea who had not
visited a health clinic for at least a year (Table 1). Fecal
samples were placed in sterile plastic specimen tubes onTable 1. Specimens collected for this study
Age groups
Control (n Z 110)
Patients with
diarrhea (n Z 95)
Male Female Male Female
1e10 0 0 7 15
11e20 2 2 3 5
21e30 9 18 5 7
31e40 3 18 5 6
41e50 6 33 9 3
51e60 0 7 5 4
61þ 3 9 10 11
Total 23 87 44 51ice and transported to our laboratory for bacterial
isolation within 3 days.
2.2. Culture procedures for isolating E. coli
Feces were plated directly on to Mac Conkey agar, or
occasionally after enrichment in trypticase soy broth
containing vancomycin (Sigma Chemical Co., St. Louis,
MO, USA). Candidate colonies were then plated onto
trypticase soy agar medium and biochemically charac-
terized using the API20E system (Biomerieux, Marcy
l’Etoile, France). For individual samples, one or two
E. coli isolates were selected randomly to determine
susceptibility.
2.3. Antimicrobial susceptibility testing
Susceptibility testing was conducted using disc
diffusion according to the guidelines of the Clinical and
Laboratory Standards Institute (formerly National
Committee For Clinical Laboratory Standards) [8].
Antimicrobial susceptibility was determined by agar
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Hinton agar (Difco, MI, USA). The following 16 anti-
biotics were tested: SAM (ampicillin-sulbactam), AM
(ampicillin), TE (tetracycline), ATM (aztreonam),
cefotetan, FEP (cefepime), FOX (cefoxitin), CTX
(cefotaxime), NN (tobramycin), SXT/TM (trimetho-
prim-sulfamethoxazole), CF (cephalothin), imipenem,
GM (gentamicin), AN (amikacin), TZP (piperacillin/
tazobactam), and NET (netilamicin). E. coli ATCC
25922 and E. coli ATCC 35218 were used as control
strains.
2.4. Statistic analysis
Antimicrobial susceptibility data were expressed as
percentages or the frequency of human isolates. A one-
way analysis of variance or c2 statistics was used to
estimate the overall difference between the percentages
or frequencies of resistance of E. coli isolates. In all
cases, p < 0.05 was regarded as statistically significant.3. Results
3.1. Bacterial isolate specimens and population
characteristics
A total of 428 E. coli isolates were obtained from the
collected fecal samples, of which 216 isolates were
derived from healthy persons and 212 pathogenic E. coli
isolates from patients with diarrhea.
3.2. Isolate antibiotic susceptibility
All isolates were analyzed by agar disc diffusion to
determine their susceptibility patterns to the 16 testedTable 3. Comparison of sex-based antibiotic resistance patterns
Antimicrobial agents
Male
No. of
resistance
No. of
non-resistance
Ra
resista
AM 36 8
SAM 11 33
TZP 1 43
CF 26 18
FEP 5 39
CTT 0 44
CTX* 10 34
FOX* 4 40
IPM 0 44
AN* 4 40
GM 18 26
NN 12 32
NET* 4 40
TE 32 12
ATM 5 39
SXT 24 20
* A p value <0.05. AM Z ampicillin; AN Z amikacin; ATM Z aztr
FEP Z cefepime; FOX Z cefoxitin; GM Z gentamicin; IPM Z im
SAM Z ampicillin-sulbactam; SXT Z trimethoprim-sulfamethoxazole; TE Zantimicrobial agents. A greater percentage of isolates
were resistant to AM (76.5% of patients with diarrhea;
77.3% of healthy persons) and TE (66% of patients with
diarrhea; 66.5% of healthy persons) in the isolates of
both groups, although no isolates showed resistance to
imipenem and cefotetan. Isolates showed higher resis-
tance to CF than other antibiotics among the cephems.
Among the aminoglycosides, the resistance to GM and
NN occurred at higher frequencies in comparison with
resistance observed for AN and NET. SXT/TM resis-
tance was also relatively higher than that for other
antibiotics. However, most E. coli isolates exhibited
a 10% resistance rate against ATM, FEP, FOX, AN, and
NET. Resistance rates were compared between the
isolates from healthy persons and patients with diarrhea
and no significant difference was found between the
groups (p < 0.05) (Table 2).
The sex- and age-specific patterns of antibiotic
resistance were further analyzed for both groups. In the
isolates from healthy persons, no significant differences
in antibiotic resistance were found among the sex and
age strata. However, in the isolates from patients with
diarrhea, sex- and age-specific patterns were observed.
As shown in Table 3, the isolates from men showed
more resistance to several antibiotics than the isolates
from women. Antibiotic resistance rates to CTX (23%
vs. 8%), FOX (9% vs. 0%), AN (9% vs. 0%), and NET
(9% vs. 0%) were also significantly higher in the isolates
from men than those from women (p < 0.05).
Isolates from patients with diarrhea in the younger
than40-years and older than40-years of age groups
showed significantly different resistances to SAM (36%
vs. 15%), FEP (2% vs. 15%), ATM (2% vs. 15%), andof the E. coli strains isolated from patients with diarrhea
Female
te of
nce (%)
No. of
resistance
No. of
non-resistance
Rate of
resistance (%)
82 40 11 78
25 16 35 31
2 1 50 2
59 29 22 57
11 2 49 4
0 0 51 0
23 4 47 8
9 0 51 0
0 0 51 0
9 0 51 0
41 18 33 35
27 6 45 12
9 0 51 0
73 33 18 65
11 2 49 4
55 25 26 49
eonam; CF Z cephalothin; CTT Z cefotetan; CTX Z cefotaxime;
ipenem; NET Z netilamicin; NN Z tobramycin; No. Z number;
tetracycline; TZP Z piperacillin/tazobactam.
Table 4. Comparison of age-based antibiotic resistance patterns of the E. coli strains isolated from patients with diarrhea
Antimicrobial agents
Younger than 40-years-old age Older than 40-years-old age
No. of
resistance
No. of
non-resistance
Rate of
resistance
No. of
resistance
No. of
non-resistance
Rate of
resistance
AM 45 8 85 23 11 68
SAM* 19 34 36 5 29 15
TZP 0 53 0 2 32 6
CF 31 22 58 18 16 53
FEP* 1 52 2 5 29 15
CTT 0 53 0 0 34 0
CTX 5 48 9 6 28 18
FOX 2 51 4 2 32 6
IPM 0 53 0 0 34 0
AN 2 51 4 2 32 6
GM 19 34 36 15 19 44
NN 8 45 15 8 26 24
NET 2 51 4 2 32 6
TE 36 17 68 25 9 74
ATM* 1 52 2 5 29 15
SXT* 32 21 60 13 21 38
*A p value <0.05. AM Z ampicillin; AN Z amikacin; ATM Z aztreonam; CF Z cephalothin; CTT Z cefotetan; CTX Z cefotaxime;
FEP Z cefepime; FOX Z cefoxitin; GM Z gentamicin; IPM Z imipenem; NET Z netilamicin; NN Z tobramycin; No. Z number;
SAM Z ampicillin-sulbactam; SXT Z trimethoprim-sulfamethoxazole; TE Z tetracycline; TZP Z piperacillin/tazobactam.
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diarrhea older than 40-years of age showed significantly
higher resistance to these antibiotics (p < 0.05)
(Table 4).
3.3. Multi-drug resistance patterns
Percentages of multiple drug resistance in E. coli
isolates for each group are given in Figure. Among the
isolates from healthy persons, 84% (181/216 isolates)
exhibited resistance to two or more antimicrobials.
Moreover, the resistance to four or more antibiotics
occurred at a frequency of 46%. Seven of the isolates were
resistant to eight antibiotics (SAM/AM/TE/NN/SXT/
GM/AN/TZP or AM/TE/FOX/NN/SXT/GM/TZP/NET).Figure. Antibiotic multi-resistance patterns of E. coli strains i
DR Z drug resistance.Among the isolates from patients with diarrhea,
78.8% (167/212) exhibited resistance to two or more
antimicrobials. There was no significant difference in
multi-drug resistance between isolates from healthy
persons and those from patients with diarrhea
(p Z 0.22). The rates of antibiotic resistance to four or
more antibiotics (37%) were similar to the rates of
healthy persons. However, the number of resistant
antibiotics was higher in the E. coli isolates from the
patients with diarrhea than those from healthy persons.
Resistance to over nine antibiotics was detected only in
the patients with diarrhea. The highest rate of resistance
was to 12 antibiotics (SAM/AM/TE/ATM/FEP/FOX/
CTX/NN/CF/GM/AN/NET). Resistance to AM insolated from patients with diarrhea and healthy individuals.
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in isolates (data not shown).4. Discussion
Judicious use of antimicrobials may be beneficial in
preserving antimicrobial efficacy and substantially
reducing diarrheal illness. However, antibiotic therapy
can further increase drug resistance in microorganisms
[3]. In this study, we examined antimicrobial resistance
of E. coli isolates from hospitalized patients due to
diarrhea and compared them to E. coli isolates from
healthy persons. The highest levels of resistance were
observed against AM and TE for both commensal and
pathogenic E. coli, which may be caused by the frequent
use of these antibiotics and the transfer of plasmids
between bacteria [9,10].
In the Enterobacteriaceae, resistance to AM is
mainly because of ß-lactamases, such as the TEM-1 and
SHV-1 enzymes, that hydrolytically cleave the ß-lactam
ring. Plasmid-encoded derivatives of the ß-lactamases
that show an enhanced spectrum of catalytic activity
have been known since the early 1980s [11]. Further-
more to the large number of ESBL-TEM and ESBL-
SHV variants, other plasmid-encoded ESBL, such as
CTX-M enzymes, are now frequently reported [12].
TE resistance in bacteria is mediated by four mecha-
nisms: efflux, ribosomal protection, enzymatic inactiva-
tion, and target modification [13]. Widespread resistance
to broad-spectrum TE has been caused, in part, by heavy
clinical use and misuse in the human population. In the
United States and other parts of the world, TEs, alone or
in combination with other antibiotics, are used for the
treatment of infectious diseases, as well as for prophy-
laxis, both orally and topically, because of their excellent
safety profile and low cost [14]. Aminoglycoside resis-
tance in E. coli most often occurs by aminoglycoside-
modifying enzymes encoded on transmissible plasmids
[14,15]. We did not determine the drug therapy for
participants with diarrheal illness or the clinical impact
of such treatment.
We found that higher resistance to the antibiotics
most frequently prescribed for diarrhea was found in
the isolates of not only the patients with diarrhea, but
also apparently-healthy persons. The higher resistance
in the greater than 40-year-old group of patients with
diarrhea may be explained by the longer exposure of
these individuals to antibiotics. The reason antibioticresistance was different between the two sexes remains
unknown, and therefore requires further investigation.Acknowledgement
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